ArticleJournal of clinical medicine2020

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations are Elevated in Patients with Neuroendocrine Malignancies.

Burcin Özdirik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.